My Quote Request
No products added yet
6505-01-310-0615
20 Products
NDC00185-0074-60
LOVASTATIN TABLETS
NSN, MFG P/N
6505013100615
NSN
6505-01-310-0615
MFG
EON LABS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOVASTATIN TABLETS 40MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LOPRESSOR
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
LOPRESSOR
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOPROLOL TARTRATE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE INJECTION USP 1MG/ML 5ML AMPUL 12S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
LOPRESSOR INJECTION
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
LOPRESSOR INJECTION
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOPROLOL TARTRATE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE INJECTION USP 1MG/ML 5ML AMPUL 12S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-2285-05
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
NDC00074-2285-05
METOPROLOL TARTRATE INJECTION,USP
NSN, MFG P/N
6505013092742
NSN
6505-01-309-2742
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METOPROLOL TARTRATE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METOPROLOL TARTRATE INJECTION USP 1MG/ML 5ML AMPUL 12S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00093-0840-92
KETOCONAZOLE CREAM
NSN, MFG P/N
6505013092744
NSN
6505-01-309-2744
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE INGREDIENT AND STRENGTH: 2.000 KETOCONAZOLE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE CREAM 60GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
NDC51672-1298-03
KETOCONAZOLE CREAM
NSN, MFG P/N
6505013092744
NSN
6505-01-309-2744
MFG
TARO PHARMACEUTICALS U.S.A. INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 2.000 KETOCONAZOLE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOCONAZOLE CREAM 60GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
F89G140
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOBETASAL PROPIONATE CREAM 45GM PLASTIC SQUEEZE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO
Related Searches:
NDC00173-0375-01
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
NDC00173-0375-01
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOBETASAL PROPIONATE CREAM 45GM PLASTIC SQUEEZE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO
Related Searches:
TEMOVATE
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
TEMOVATE
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOBETASAL PROPIONATE CREAM 45GM PLASTIC SQUEEZE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO
Related Searches:
TEMOVATE CREAM
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
TEMOVATE CREAM
CLOBETASOL PROPIONATE LOTION
NSN, MFG P/N
6505013092745
NSN
6505-01-309-2745
MFG
GLAXO WELLCOME INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOBETASAL PROPIONATE CREAM 45GM PLASTIC SQUEEZE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GLAXO
Related Searches:
NDC00143-1780-01
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505013093244
NSN
6505-01-309-3244
NDC00143-1780-01
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS
NSN, MFG P/N
6505013093244
NSN
6505-01-309-3244
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT AND 325.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: CARD
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE III
SUPPLEMENTARY FEATURES: REVERSE NUMBERD BLISTER CARD
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00016-0310-55
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013096639
NSN
6505-01-309-6639
NDC00016-0310-55
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505013096639
NSN
6505-01-309-6639
MFG
ADVANCED MEDICAL OPTICS INC. DBA A M O
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM HYALURONATE INJECTION 10MG/ML 0.55ML SYRINGE
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.550 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PH OF 7.0 TO 7.5; EACH ML ALSO CONTAINS: 8.5 MG SODIUM CHLORIDE,0.28 MG DISODIUM HYROGEN PHOSPHATE DIHYDRATE,0.04 MG SODIUM DIHYDROGEN PHOSPHATE HYDRATE,1.0 ML (QSAD) WATER FOR INJECTION,USP; DISPOSAL PRE-FILLED GLASS SYRINGE,W/27 GAUGE SINGLE USE CANNULA
Related Searches:
5505-101
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
5505-101
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00019-5505-10
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
NDC00019-5505-10
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013097318
NSN
6505-01-309-7318
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
CARTROL
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
CARTROL
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CARTEOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARTEOLOL HYDROCHLORIDE TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CARTROL TABLETS
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
CARTROL TABLETS
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CARTEOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARTEOLOL HYDROCHLORIDE TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-1665-13
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
NDC00074-1665-13
CARTEOLOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505013100612
NSN
6505-01-310-0612
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CARTEOLOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARTEOLOL HYDROCHLORIDE TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MEVACOR
LOVASTATIN TABLETS
NSN, MFG P/N
6505013100615
NSN
6505-01-310-0615
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOVASTATIN TABLETS 40MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00006-0732-61
LOVASTATIN TABLETS
NSN, MFG P/N
6505013100615
NSN
6505-01-310-0615
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS LOVASTATIN ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOVASTATIN TABLETS 40MG 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
